SUPD
For someone with diabetes, statin use is an important part of risk reduction to avoid heart attack and stroke. This app helps clinicians determine who can safely restart taking a statin for their potentially life-saving benefits!
Shilling for Amgen
Why the ACC would feel compelled to create a specific sales tool for Amgen or any PCSK9 manufacturer is beyond the ethics of most fellow cardiologists. You know how this is corrupt? Look for a corresponding PCSK9 neurologic side effect reporting app. Can't find it? Yeah. Happy to fund intolerance app for statin, oh whoops our pockets are empty even though this new snake oil is $10k/year.
Show less
